October is Medical Ultrasound Awareness Month (MUAM)!
During MUAM and in the coming months, ASE will share #ILookLikeASonographer social media posts to celebrate our sonographer members and increase awareness about this important and rewarding profession.
Additionally, and ASEF will shine a spotlight on ultrasound professionals all month long. Submit a photo of a sonographer you with with along with an appreciation message to Mary Carmody. Submissions will be shared on ASEF’s website.
Thank you to everyone who uploaded echo images and voted on Connect@ASE during the Image Calendar Competition. Please join ASE in congratulating the following members, whose images have been selected for the 2023 ASE Image Calendar:
To receive your copy of the 2023 Image Calendar, renew your ASE membership by December 31, 2022!
Submit your abstract of original research or clinical cases to be considered for presentation at the premier cardiovascular ultrasound conference of the year, the 34th Annual ASE Scientific Sessions in National Harbor, Maryland, June 23-26, 2023.
Begin your submission online today! Presenters benefit from dedicated viewing times, a global audience that promotes future collaborative work, eligibility for travel support, publication in JASE, and discounted conference registration rates. Visit the ASE 2023 Call for Science for more information. Submission closes Wednesday, February 8, 2023, 11:59 ET
The October JASE includes, “Simplified Lung Ultrasound Examination and Telehealth Feasibility in Early SARS-CoV-2 Infection,” from Drs. Kimura, Resnikoff, Tran, Bonagiri, and Spierling Bagsic.
Dr. Kimura noted, “Although the nature of SARS-CoV-2 infection seems to be constantly changing, we found that the use of a quick-and-easy ultrasound exam can help identify outpatients with early lung involvement and a worse prognosis, even before detection by skin temperature or pulse oximetry. The simplicity of the exam enabled patients to image themselves from isolation and suggests the feasibility of imaging from home, a school, a pharmacy, or even a drive-through testing site. The COVID-19 pandemic taught us a new pathway to apply ultrasound which may involve a combination of simplified self-imaging, telehealth, and artificial intelligence, that will improve healthcare delivery from within the community on a variety of diseases in the future.”
Another COVID-19 study looks at serial left and right ventricular strain analysis in patients who have recovered from the infection. Additional clinical investigations also look at 3D echocardiography, incremental value of global longitudinal strain to stress echocardiography in outcome assessment, several topics related to tricuspid and mitral regurgitation, left atrial function and outcomes in cryptogenic stroke, transcatheter aortic valve replacement in children, and enhancing quality in pediatric echocardiography.
Two brief research communications round out the issue. The President’s Message from Stephen H. Little, MD, FASE, shares the multi-faceted ways that ASE is a global organization, and why this incredible diversity is so important to the future of advancing cardiovascular ultrasound. The continuing education and meeting calendar outlines a multitude of learning options near and far.
The October 19 deadline to submit papers to be considered for the JASE Echocardiography in Valvular Heart Disease focus issue (published in early 2023) is almost here. Questions? Contact JASE managing editor, Debbie Meyer, at dmeyer@asecho.org
ASE is seeking the best and brightest members to move forward the mission and goals of the Society and the ASE Foundation. Now is your opportunity to become a leader in ASE! The deadline for submission of nominations is November 30, 2022. Ask an active ASE member TODAY to submit your nomination. Please contact Nominations@ASEcho.org with any questions or to submit nominations.
(DURHAM, NC, Sept. 29, 2022)—The American Society of Echocardiography (ASE) is targeting its research funding over the next five years to help solve some of the mysteries around the early detection of a common form of heart failure. ASE is one of the key partner organizations in a joint research initiative that aims to identify more precise treatment strategies for patients suffering from heart failure with preserved ejection fraction (HFpEF).
The Accelerating Medicines Partnership® Heart Failure (AMP® HF) Program will utilize more than $37 million in funding from private and public collaborators—which includes ASE—to better diagnose and develop treatment options for HFpEF and improve the outlook for millions of patients around the world. The Foundation for the National Institutes of Health (FNIH) and the National Heart Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH) will facilitate the program over the next five years.
“One of ASE’s current strategic goals is to focus our efforts where they are most needed,” says Stephen H. Little, MD, FASE, FRCPC, FACC, ASE’s 2022-2023 Board of Directors President. “The Society is proud to support research projects like AMP HF because of the great promise the findings can have in advancing the field of cardiovascular ultrasound and improving patient care.”
HFpEF is a common form of heart failure that is difficult to detect. It is often deadly, with a five-year survival rate of just 35-40%. In addition to a high risk for mortality, patients with HFpEF live with declining quality of life and poor capacity to perform tasks of daily living.
The AMP HF Program will advance the understanding of HFpEF using two complementary and integrated research components: analyzing existing HFpEF datasets, sourced from public and private sector funded studies, and initiating a new clinical trial to confirm retrospective findings in an observational cohort with a goal to develop a framework for new precision treatments.
“Echocardiography is a specialty that already plays a significant role in diagnosing heart conditions, and we look forward to continuing to learn how echocardiographic screenings can be used in understanding the many still unanswered questions about HFpEF,” says Judy Hung, MD, FASE, who is a cardiologist with Massachusetts General Hospital and an ASE past president.
“Research shapes the future of medicine, and ASE is honored to be among some of the largest and most innovative biomedical partners contributing to this important initiative,” Dr. Hung added.
ASE’s charitable arm, the ASE Foundation, provides support for initiatives that are not funded by membership dues—such as training scholarships and scientific research. In the last 25 years, the Society and its Foundation have contributed more than $7.3 million to cardiovascular health research.
About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, Twitter or LinkedIn.
About the Foundation for the National Institutes of Health: The Foundation for the National Institutes of Health (FNIH) creates and manages alliances with public and private institutions in support of the mission of the NIH. FNIH works with its partners to accelerate biomedical research and strategies against diseases and health concerns in the United States and across the globe. The FNIH organizes and administers research projects; supports education and training of new researchers; organizes educational events and symposia; and administers a series of funds supporting a wide range of health issues—all efforts focused on areas of unmet need, paving the way toward better patient experiences and outcomes. Established by Congress in 1990, the FNIH is a not-for-profit 501(c)(3) charitable organization. For additional information about the FNIH, please visit https://fnih.org.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/.
The latest issue of CASE, ASE’s open access case reports journal, is available, and is packed with educational material to share with trainees and colleagues, including another fantastic article authored by a sonographer.
Editor-in-Chief Vincent Sorrell, MD, FASE, remarked, “The sonographer-led CASE report on the incidental finding of an anonymous coronary artery by Okoli e.t al. was a wonderfully clever update that provided both the sonographer and physician perspectives. When you read the conclusions, you may be struck by the list of items the Medical Doctor has to consider when faced with this diagnosis: Management Dilemmas; Most Desirable imaging options; Most Decisive information to review; Most Dreaded complication risks; Most Definitive treatments; and Most Daunting remaining questions. It was a great reminder that sonographers provide unique perspectives beyond the MD.”
Additionally, this issue includes three cases highlighting the value of Multimodality Imaging in multiple diseases, two additional Congenital Heart Disease cases, and two cases in the Interventional Echocardiography section, including a novel report on echo-guided PIMSRA for residual LVOTO in HCM patients. The editorial from Dr. Sorrell, “Distracted Driving in the Echo Lab,” reflects on the challenges for medical professionals to stay focused amidst our modern daily life full of multi-tasking and disruptions.
We hope this issue of CASE provides new insights and inspires more sonographers to continue authoring and submitting their own case reports. There are still open access fee waivers for sonographers available, sponsored by the Council on Cardiovascular Sonography, waiting to be claimed by you!
Email Debbie Meyer, Director of Publications (JASE, CASE), or Andie Piddington, Deputy Managing Editor (JASE, CASE), with any questions or to request a case-writing mentorship from an ASE sonographer
ASE is hosting a free webinar, Five Years of #ASEchoJC: How You Can Learn from Our Journey and Get Involved, on Thursday, September 29, 5:00 PM ET. The webinar will explain the best practices, tips, and tricks for successfully engaging and getting involved with ASE’s Twitter Journal Club (#ASEchoJC).
Attendees will hear the experiences and perspectives of four speakers from different backgrounds who will discuss how being involved in social media and #ASEchoJC has helped them in education, diffusion of scientific work, and their professional development. This is a great way to learn more and get your questions answered about #ASEchoJC.
After the webinar, make plans to attend the #ASEchoJC on September 29, at 8:00 PM ET.
Webinar attendees and #ASEchoJC participants can earn 1.0 AMA PRA Category 1 Credit™ for their participation in both the webinar and #ASEchoJC.
At the end of this month, the ASE Foundation will host its popular Coffee Day fundraiser from September 25 – October 1. Share a cup of joe with ASEF in honor of National Coffee Day on September 29 by making a donation in the amount you normally spend on a cup of coffee!
After you donate, let us know on social media by tagging @ASE360 with a picture of your coffee, or better yet, a coffee selfie, using the hashtags #ASEFoundation #GaveACup. We want to virtually “cheers” you for your contribution to our 2022 Annual Appeal! We set a goal to raise $5,000.
Interested in making an early pledge to help us wake up other donations? Contact Mary Carmody at MCarmody@ASEcho.org. Remember, every donation helps to fuel Foundation scholarships, research grants, global outreach patient efforts, and more!
The September JASE includes, “Natural History of Mitral Annular Calcification and Calcific Mitral Valve Disease,” from Drs. Willner, Burwash, Beauchesne, Chan, Vulesevic, Ascah, Toutinho, Promislow, Stadnick, Chan, Mesana, and Messika-Zeitoun.
Willner et al. graphic abstract.
Dr. Messika-Zeitoun noted, “Mitral severe annular calcification (MAC) and calcific mitral valve disease (CMVD) are common and progressive diseases, but their natural history remained poorly defined. In this large cohort of patients with paired echocardiograms, we showed progression to severe MAC was common and frequently results in CMVD with higher progression rates observed in women suggesting sex-differences in MAC/CMVD pathophysiology. The challenges posed by MAC for both transcatheter and surgical interventions and the observation that most patients with CMVD are left conservatively managed irrespective of their functional status underline the importance of better understanding the pathophysiology of MAC and CMVD and of developing effective preventive medical therapies.”
Two other clinical investigations also look at echocardiography in mitral valve disease. Additional clinical investigations explore strain echocardiography in aortic stenosis, the value of echocardiography in evaluation of dyspnea, 3D echocardiography assessment of atrioventricular coupling in infants and children, and open-source software used in the visualization and quantification of the unrepaired complete atrioventricular canal valve in children. A Special Article, “Practical Points for Echocardiography in Cardiac Amyloidosis,” was created by the ASE Amyloidosis Task Force as an accompaniment to the recently published multisociety Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis. A review article looks at cardiac imaging for diagnosis and management of infective endocarditis, and this issue also includes Dr. Denisa Muraru’s 22nd Annual Feigenbaum Lecture that was given at the 2021 ASE Scientific Sessions.
A brief research communication, editorials, and correspondence round out the issue. The President’s Message from Stephen H. Little, MD, FASE, with guest writer David H. Wiener, MD, FASE, elucidates ASE’s initiative to create living guidelines. The continuing education and meeting calendar outlines a multitude of learning options near and far.
